- Home
- PAVM vs DOMH Comparison
PAVM vs DOMH Comparison
Compare PAVM & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- DOMH
- Stock Information
- Founded
- PAVM 2014
- DOMH 1967
- Country
- PAVM United States
- DOMH United States
- Employees
- PAVM N/A
- DOMH N/A
- Industry
- PAVM Medical/Dental Instruments
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- PAVM Health Care
- DOMH Health Care
- Exchange
- PAVM Nasdaq
- DOMH Nasdaq
- Market Cap
- PAVM 8.2M
- DOMH 74.9M
- IPO Year
- PAVM 2016
- DOMH N/A
- Fundamental
- Price
- PAVM $0.59
- DOMH $5.32
- Analyst Decision
- PAVM Strong Buy
- DOMH
- Analyst Count
- PAVM 1
- DOMH 0
- Target Price
- PAVM $19.00
- DOMH N/A
- AVG Volume (30 Days)
- PAVM 209.6K
- DOMH 1.6M
- Earning Date
- PAVM 03-25-2025
- DOMH 05-08-2025
- Dividend Yield
- PAVM N/A
- DOMH 5.66%
- EPS Growth
- PAVM N/A
- DOMH N/A
- EPS
- PAVM 0.53
- DOMH N/A
- Revenue
- PAVM $4,034,000.00
- DOMH $12,589,000.00
- Revenue This Year
- PAVM $52.90
- DOMH N/A
- Revenue Next Year
- PAVM $248.84
- DOMH N/A
- P/E Ratio
- PAVM $1.16
- DOMH N/A
- Revenue Growth
- PAVM 166.27
- DOMH 1117.50
- 52 Week Low
- PAVM $0.57
- DOMH $0.83
- 52 Week High
- PAVM $2.84
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- PAVM 43.42
- DOMH 46.01
- Support Level
- PAVM $0.59
- DOMH $5.18
- Resistance Level
- PAVM $0.70
- DOMH $8.55
- Average True Range (ATR)
- PAVM 0.06
- DOMH 1.42
- MACD
- PAVM -0.01
- DOMH -0.57
- Stochastic Oscillator
- PAVM 21.23
- DOMH 7.68
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.